The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
FRANKFURT: The CEO of pharmaceuticals giant Roche, opens new tab said authorities should block the takeover of contract drug ...
An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
Medpage Today on MSN2d
Potentially Large Cost Savings With Home-Based OCT for Neovascular AMDCHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...
Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...
At the forefront of poultry production, USPOULTRY's 2024 Live Production, Welfare and Biosecurity Seminar — held in Tucker, ...
11 This reflects the importance of such meetings that urge the healthcare community to stand united in the fight against heart failure and its interconnected conditions.” As a leading ...
Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...
Global Pleural Diseases Therapeutics Market to Reach USD 9.4 Billion by 2033, Growing at a 6.5% CAGR
Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...
GoodRx announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira Thursday, adding to an increasingly competitive market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback